Taumedis is a Canadian medical technology company developing the next generation of intraoperative imaging — bringing real-time MRI, Positron Emission Tomography (PET), and Ultrasound directly into the operating room, while introducing Dual-Mode Imaging technology into breast cancer screening workflows.
Origin
The name Taumedis is an acronym for tau Medical Imaging Solutions, where the Greek letter tau (τ) has significance in magnetic resonance imaging and a variety of neurodegenerative diseases. Technology development began in 2018 by a group of Canadian scientists and engineers passionate about medical imaging; with over 70 years of collective experience in the field, the Taumedis team strives to develop the highest quality intraoperative and diagnostic imaging solutions to hospitals, clinics, and research facilities.
Location
Winnipeg, Manitoba is home to Taumedis, strategically located at the geographic center of North America. Winnipeg has a rich heritage of medical imaging R&D going back to the National Research Council Institute for Biodiagnostics (NRC-IBD), a research laboratory established in 1992 that aimed to investigate and develop non-invasive medical diagnostic technology for the prevention, early diagnosis, and improved treatment and prognosis of diseases. The NRC-IBD focused on areas of magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), and infrared spectroscopy (IRS), spawning a variety of technological innovations that stood at the forefront of their respective modalities.
